About iGENETECH
MISSION
To provide accessible and accurate diagnostic solutions globally,
bridging the gap between developed and developing nations.
VISION
World-class clinical pathologist's skills transfered into Point-of-Care,
powered by simple & precise robotics
Core Offering
Affordable and portable All-in-One Point-of-Care (POC)
Molecular & Immuno Diagnostics Platform.
About iGENETECH
MISSION
To provide accessible and accurate diagnostic solutions globally,
bridging the gap between developed and developing nations.
VISION
World-class clinical pathologist's skills transfered into Point-of-Care,
powered by simple & precise robotics
Core Offering
Affordable and portable All-in-One Point-of-Care (POC) Molecular & Immuno Diagnostics Platform.
CEO
JinSeok Kang
Founder of Ct labs Inc. and joined
iGENETECH as CEO in 2023
Strong industrial experience in molecular diagnostic kit
development and commercialization as a managing
director/team leader over 20years
CTO
Kyoung Ho Kim
Founder of iGENETECH Inc.
Expert in the design of optical and immuno/molecular
diagnostic equipment
Experienced as a director and team leader from design
to mass production in the industry
CSO
Derek Lee
Our History
2025
Business expansion
Q1~Q2
Full-scale Business Collaboration via Platform Migration (Companies S, G, B)
ISO13485 Quality Certification (MD 816270)
Veterinary Product License: MoiM Dx200 (No. 484-002)
Research Published in Scientific Reports (with Asan Medical Center)
Registration of Core Patent (10-2814100) & Design (30-1313968)
Selected for DIPS 1000+ Project (Super Gap Startup, MSS)
Awarded KHIDI Gov't Project (with Samsung Medical Center)
Global Collaboration for R&D & Commercialization (R2D2; Clinical Trials in Zambia)
Q3~Q4
Full-scale Business Collaboration via Platform Migration (Company G, India)
Inno-Biz Certification (Technology Innovation SME)
Selected as 'First Penguin' Enterprise (KODIT)
HQ Relocation to Gongse-dong
2024
Business commer cialization
Q1~Q2
Lyo-bead ODM contract with Median Diagnostics Inc.
Lyo-bead ODM contract with Sanigen Inc.
MAFRA R&D fund
Established a joint development agreement for on-site diagnostic products with Median Diagnostics
Selected for the Scale-up TIPS startup project
Established a manufacturing plant in Anyang
Selected for an investment attraction support project linked with investment institutions
Selected for the K-Bio Health support project
Obtained Class II equipment regulatory approval for MoiM Dx100
Obtained manufacturing authorization for in vitro diagnostic medical devices
Q3~Q4
Obtained GMP certification
Signed ODM contract (Company S1)
Developed, manufactured, and secured a supply contract for a multi-wavelength absorbance detection jig (Company S2)
Developed and secured a supply contract for a prototype analyzer (Company S2)
Contracted for viewer development services (Company S3)
Contracted for the commissioned development of TB/NTM Real Time-PCR (Company S3)
Obtained manufacturing authorization for veterinary medical devices
Obtained ISO 9001:2015 certification
Obtained regulatory approval for the veterinary medical device MoiM Dx100
Received Class II device approval for MoiM Dx200
Secured a global supply agreement for custom formulation freeze-dried diagnostic raw materials (with R1 company)
Successfully raised Series A funding
2023
Business Development
Q1~Q2
Collaborative development of animal
diagnostic platform with Soulbrain Inc.
Commencement of reagent material supply
KHIDI R&D fund
K-startup fund
KCDC microbiome research fund
R&D center opened
Yong-in ICT smart production fund
Approved as a venture company
GFID R&D fund (Infectious disease prevention system)
Q3~Q4
Innocuve fund / C & Venture partners fund
Deep tech R&D fund
Accelvest investment fund
2022
Company founded
Q1~Q4
Establishment of iGentec Inc.
Completion of Prelim. Startup Package (Outstanding)
Seed Investment (KRW 850M, Strategic SI)
Recruitment of 2 Key Personnel
Platform Layout Design
Detailed Platform Design
Development of Key Reagent Technologies
Filing of Core Patents
Our History
2025
Business expansion
Q1~Q2
Full-scale Business Collaboration via Platform Migration (Companies S, G, B)
ISO13485 Quality Certification (MD 816270)
Veterinary Product License: MoiM Dx200 (No. 484-002)
Research Published in Scientific Reports (with Asan Medical Center)
Registration of Core Patent (10-2814100) & Design (30-1313968)
Selected for DIPS 1000+ Project (Super Gap Startup, MSS)
Awarded KHIDI Gov't Project (with Samsung Medical Center)
Global Collaboration for R&D & Commercialization (R2D2; Clinical Trials in Zambia)
Q3~Q4
Full-scale Business Collaboration via Platform Migration (Company G, India)
Inno-Biz Certification (Technology Innovation SME)
Selected as 'First Penguin' Enterprise (KODIT)
HQ Relocation to Gongse-dong
2024
Business commer cialization
Q1~Q2
Lyo-bead ODM contract with Median Diagnostics Inc.
Lyo-bead ODM contract with Sanigen Inc.
MAFRA R&D fund
Established a joint development agreement for on-site diagnostic products with Median Diagnostics
Selected for the Scale-up TIPS startup project
Established a manufacturing plant in Anyang
Selected for an investment attraction support project linked with investment institutions
Selected for the K-Bio Health support project
Obtained Class II equipment regulatory approval for MoiM Dx100
Obtained manufacturing authorization for in vitro diagnostic medical devices
Q3~Q4
Obtained GMP certification
Signed ODM contract (Company S1)
Developed, manufactured, and secured a supply contract for a multi-wavelength absorbance detection jig (Company S2)
Developed and secured a supply contract for a prototype analyzer (Company S2)
Contracted for viewer development services (Company S3)
Contracted for the commissioned development of TB/NTM Real Time-PCR (Company S3)
Obtained manufacturing authorization for veterinary medical devices
Obtained ISO 9001:2015 certification
Obtained regulatory approval for the veterinary medical device MoiM Dx100
Received Class II device approval for MoiM Dx200
Secured a global supply agreement for custom formulation freeze-dried diagnostic raw materials (with R1 company)
Successfully raised Series A funding
2023
Business
Development
Q1~Q2
Collaborative development of animal diagnostic platform with Soulbrain Inc.
Commencement of reagent material supply
KHIDI R&D fund
K-startup fund
KCDC microbiome research fund
R&D center opened
Yong-in ICT smart production fund
Approved as a venture company
GFID R&D fund (Infectious disease prevention system)
Q3~Q4
Innocuve fund / C & Venture partners fund
Deep tech R&D fund
Accelvest investment fund
2022
Company founded
Q1~Q4
Establishment of iGentec Inc.
Completion of Prelim. Startup Package (Outstanding)
Seed Investment (KRW 850M, Strategic SI)
Recruitment of 2 Key Personnel
Platform Layout Design
Detailed Platform Design
Development of Key Reagent Technologies
Filing of Core Patents
Certificates & Patents
Veterinary Medical Device Manufacturing License
IVD Medical Device Manufacturing License
GMP
ISO 9001:2015
ISO 13485:2016
